This new report provides an analysis of the major home/self-testing market segments, including diabetes (strips and meters), pregnancy, ovulation, and occult blood. The report presents trends, dynamics, size, growth, regulatory requirements, technologies, and competitive profiles.
Rationale
The growing economic pressures on hospitals, coupled with advances in diagnostic technologies, intensifying competition among suppliers and physicians, and changing consumer demands are shifting diagnostic testing from hospitals and commercial laboratories closer to the patient.Market Segmentation Analysis
- Review of the home/self-testing market segments, including diabetes (strips and meters), pregnancy, ovulation and occult blood.
- Five-year sales forecasts.
Competitive Assessments
- Assessments of major POC suppliers and emerging market entrants.
Methodology
This report is based on a combination of primary and secondary sources of information, including review of the latest technical and business publications, manufacturer product literature, industry analyst reports, and the publisher's proprietary data files.Companies Mentioned
- Abbott
- Accriva
- Agilent Technologies
- Axis-Shield
- Beckman Coulter/Danaher
- Becton Dickinson
- Bio/Data
- bioMerieux
- Bio-Rad
- Cepheid
- Chrono-Log
- Corgenix
- Decode Genetics
- Diagnostica Stago
- Diamedix
- DiaSorin
- Eiken Chemical
- EKF Diagnostics
- Fujirebio
- Grifols
- Helena Laboratories
- Hologic
- Horiba
- Instrumentation Laboratory/Werfen
- Kyowa Medex
- Leica Biosystems
- Lonza
- Nihon Kohden
- Ortho-Clinical Diagnostics
- Polymedco
- Qiagen
- Roche
- SDIX
- Sekisui Diagnostics
- Sequenom
- Siemens Healthineers
- Sienco
- Sysmex
- Takara Bio
- Thermo Fisher
- Tosoh
- Wako
